Cancer data in Australia, About age-adjusted survival - Australian Institute of Health and Welfare
Fig. 3, [Kaplan-Meier curves showing overall survival...]. - Brain and Human Body Modeling 2020 - NCBI Bookshelf
Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trials | BMJ Open
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer
A prognostic nomogram for overall survival in male breast cancer with histology of infiltrating duct carcinoma after surgery [PeerJ]
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study - Journal of Hepatology
Overall survival of patients with EGFR mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland – real-world data
TROPiCS-02 Results | TRODELVY® (sacituzumab govitecan-hziy) | Official HCP Site
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer | NEJM
Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine | Journal of Hematology & Oncology | Full Text
562 Overall survival rates and progression free survival in IDS vs PDS in advanced ovarian cancer patients in the university hospitals of Leicester | International Journal of Gynecologic Cancer
Cancers | Free Full-Text | Development of a Prognostic Model of Overall Survival for Metastatic Hormone-Naïve Prostate Cancer in Japanese Men
The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients | British Journal of Cancer
Overall survival of black and white men with metastatic castration-resistant prostate cancer (mCRPC): a 20-year retrospective analysis in the largest healthcare trust in England | Prostate Cancer and Prostatic Diseases
Nivolumab Boosted Survival in Relapsed Mesothelioma - ILCN.org (ILCN/WCLC)
LIBTAYO® (cemiplimab-rwlc) Overall Survival Rate in Advanced NSCLC
図11 Overall Survival (Updated)
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
Cancers | Free Full-Text | Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma